In our study, except for the bilirubin levels, other clinical variables were no significant different among the four UGT1A1 genotype groups; (3) the genetic variant affect the consequence (NAFLD) only through the risk factor (bilirubin). Here, UGT1A1 is linked to metabolic dysfunction-associated steatotic liver disease.